The full report, orders for each agency, and additional background on IRRC’s review of existing regulations can be found here: https://www.irrc.state.pa.us/documents/review_of_existing_regulations.cfm |
Regulation #10-173: Schedules of Controlled Substances
Reschedules: Estazolam from Schedule I to IV; Buprenorphine from Schedule V to III; and adds Butorphanol, Sibutramine and Zolpidem to Schedule IV controlled substances
IRRC Number | 2340 | Proposed Regulation Received | April 17, 2003 |
Agency Name | Department of Health | PA Bulletin Publish Date | May 03, 2003 |
Regulation Status | Final-Form | Close of Public Comment | June 02, 2003 |
PA Code | 28 Pa. Code Chapter 25 | Final Due By | June 02, 2005 |
Analysts Assigned |
Mary Lou Harris (MLH) Scott R. Schalles (SRS) James M. Smith (JMS) |
IRRC Comments Due | July 02, 2003 |
Final-Form Regulation Received | January 28, 2004 | ||
Public Meeting Date | March 11, 2004 | ||
Published as Final | N/A | ||
Actions Taken | |||
Approved by Law (no comments Section 5(g) ) | March 10, 2004 | ||
House Committee Deems Regulation Approved | March 10, 2004 | ||
Senate Committee Deems Regulation Approved | March 10, 2004 |
- Proposed Regulation
- Final Regulation
- Related Documents
|
|
In addition to comments, IRRC occasionally receives other correspondence and written materials from state agencies and the legislature regarding pending regulations. These documents can be found on this portion of our website.
There are currently no related documents. |